Qualigen Therapeutics, Inc. ( QLGN) - Stock Earnings
Stock symbol QLGN is outdated, potentially delisted? Maybe it is available on other exchange?
QLGN Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 18, 2026, midnight | — / — | — | — / — | — |
QLGN Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q1 | -8.5 million USD | 1.4 million USD |
| 2023Q2 | -3.5 million USD | 1.6 million USD |
| 2023Q3 | -3.7 million USD | — USD |
QLGN Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2021 | -17.9 million USD | 5.7 million USD |
| 2022 | -21.0 million USD | 5.0 million USD |
| 2023 | -17.3 million USD | 5.0 million USD |
QLGN
Price: $3.04
52 week price:
Earnings Per Share: 6.30 USD
P/E Ratio: 0.45
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 69100
Market Capitalization: 4.8 million